Ceftiofur susceptibility of streptococcus equi subsp zooepidemicus isolated from horses in North America between 1989 and 2008

Veterinary Therapeutics

Volumn 10, Issue 4, 2009, Pages

  Bade, Donald J ^a   Sibert, Gary J ^b   Hallberg, John ^b   Portis, Ellen S ^b   Boucher, Joseph ^b   Bryson, Lawrence ^b  

^a Microbial Research Inc   (United States)

^b ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE; STREPTOCOCCUS EQUI;

EID: 77349093552     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Wood JL, Burrell MH, Roberts CA, et al. Streptococci and Pasteurella spp. associated with disease of the equine lower respiratory tract. Equine Vet J 1993;4:314-318.
2. Clark C, Greenwood S, Boison JO, et al. Bacterial isolates from equine infections in western Canada (1998-2003). Can Vet J 2008;49:153-160.
3. ® (200 mg/ml) Administered Twice at a Five Day Interval at 6.6 mg/kg BW in Horses for the Treatment of Lower Respiratory Disease Associated with Streptococcus zooepidemicus or Other Relevant Bacterial Pathogens. New York: Pfizer Animal Health; 2009.
4. National Committee on Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals: Approved Standard. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2002. CLSI document M31-A2.
5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals: Approved Standard. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008. CLSI document M31-A3.
6. Clinical and Laboratory Standards Institute Subcommittee on Veterinary Antimicrobial Susceptibility Testing. Summary Minutes. Meeting at the Grand Hyatt Tampa Bay, Tampa, FL, January 24-25, 2008.
7. SR 8651R-85-08-161. Streptococcus equi subsp. zooepidemicus from US, Canada, and EU Field Studies: MBC and Time-Kill Assessments. New York: Pfizer Animal Health; 2008.